Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine for Reperfusion Injury in Lower Limb Ischemia
NCT02117206Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Nov 2005
- Primary completion
- Mar 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arginine in Peripheral Arterial Disease (PAD), reperfusion injury (IRI), sponsored by Strasbourg University Hospital. Started Nov 2005; status: completed.
02
Drugs
arginine
03
Conditions
Peripheral Arterial Disease (PAD)reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02117206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117206.